Literature DB >> 26224052

Marked alterations of neutrophil functions during sepsis-induced immunosuppression.

Julie Demaret1, Fabienne Venet1, Arnaud Friggeri1, Marie-Angélique Cazalis1, Jonathan Plassais1, Laurent Jallades1, Christophe Malcus1, Françoise Poitevin-Later1, Julien Textoris1, Alain Lepape1, Guillaume Monneret2.   

Abstract

Severe septic syndromes deeply impair innate and adaptive immunity and are responsible for sepsis-induced immunosuppression. Although neutrophils represent the first line of defense against infection, little is known about their phenotype and functions a few days after sepsis, when the immunosuppressive phase is maximal (i.e., between d 3 and 8). The objective of the present study was to perform, for the first time, a global evaluation of neutrophil alterations in immunosuppressed septic patients (at d 3-4 and d 6-8) using phenotypic and functional studies. In addition, the potential association of these parameters and deleterious outcomes was assessed. Peripheral blood was collected from 43 septic shock patients and compared with that of 23 healthy controls. In the septic patients, our results highlight a markedly altered neutrophil chemotaxis (functional and chemokine receptor expressions), oxidative burst, and lactoferrin content and an increased number of circulating immature granulocytes (i.e., CD10(dim)CD16(dim)). These aspects were associated with an increased risk of death after septic shock. In contrast, phagocytosis and activation capacities were conserved. To conclude, circulating neutrophils present with phenotypic, functional, and morphologic alterations a few days after sepsis onset. These dysfunctions might participate in the deleterious role of sepsis-induced immunosuppression. The present results open new perspectives in the mechanisms favoring nosocomial infections after septic shock. They deserve to be further investigated in a larger clinical study and in animal models recapitulating these alterations. © Society for Leukocyte Biology.

Entities:  

Keywords:  CD10; CD16; myeloperoxidase; septic shock

Mesh:

Substances:

Year:  2015        PMID: 26224052     DOI: 10.1189/jlb.4A0415-168RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  64 in total

Review 1.  Immunometabolism: Another Road to Sepsis and Its Therapeutic Targeting.

Authors:  Vijay Kumar
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

2.  Expression of Stromal Cell-Derived Factor-1 by Mesenchymal Stromal Cells Impacts Neutrophil Function During Sepsis.

Authors:  Min-Young Kwon; Sailaja Ghanta; Julie Ng; Konstantin Tsoyi; James A Lederer; Roderick T Bronson; Souheil El-Chemaly; Su Wol Chung; Xiaoli Liu; Mark A Perrella
Journal:  Crit Care Med       Date:  2020-05       Impact factor: 7.598

Review 3.  Endotoxemia-menace, marker, or mistake?

Authors:  Robert S Munford
Journal:  J Leukoc Biol       Date:  2016-07-14       Impact factor: 4.962

Review 4.  Advances in the understanding and treatment of sepsis-induced immunosuppression.

Authors:  Fabienne Venet; Guillaume Monneret
Journal:  Nat Rev Nephrol       Date:  2017-12-11       Impact factor: 28.314

Review 5.  Therapeutic targeting of neutrophil exocytosis.

Authors:  Sergio D Catz; Kenneth R McLeish
Journal:  J Leukoc Biol       Date:  2020-01-28       Impact factor: 4.962

6.  Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1.

Authors:  Andriani C Patera; Anne M Drewry; Katherine Chang; Evan R Beiter; Dale Osborne; Richard S Hotchkiss
Journal:  J Leukoc Biol       Date:  2016-09-26       Impact factor: 4.962

7.  Frontline Science: HMGB1 induces neutrophil dysfunction in experimental sepsis and in patients who survive septic shock.

Authors:  Murielle Grégoire; Jean-Marc Tadié; Fabrice Uhel; Arnaud Gacouin; Caroline Piau; Nathaniel Bone; Yves Le Tulzo; Edward Abraham; Karin Tarte; Jaroslaw W Zmijewski
Journal:  J Leukoc Biol       Date:  2016-12-13       Impact factor: 4.962

8.  Early PREdiction of sepsis using leukocyte surface biomarkers: the ExPRES-sepsis cohort study.

Authors:  Manu Shankar-Hari; Deepankar Datta; Julie Wilson; Valentina Assi; Jacqueline Stephen; Christopher J Weir; Jillian Rennie; Jean Antonelli; Anthony Bateman; Jennifer M Felton; Noel Warner; Kevin Judge; Jim Keenan; Alice Wang; Tony Burpee; Alun K Brown; Sion M Lewis; Tracey Mare; Alistair I Roy; John Wright; Gillian Hulme; Ian Dimmick; Alasdair Gray; Adriano G Rossi; A John Simpson; Andrew Conway Morris; Timothy S Walsh
Journal:  Intensive Care Med       Date:  2018-10-05       Impact factor: 17.440

9.  Wnt/β-Catenin Antagonist Pyrvinium Exerts Cardioprotective Effects in Polymicrobial Sepsis Model by Attenuating Calcium Dyshomeostasis and Mitochondrial Dysfunction.

Authors:  Pallavi Sen; Kirti Gupta; Abha Kumari; Gaaminepreet Singh; Sneha Pandey; Ragini Singh
Journal:  Cardiovasc Toxicol       Date:  2021-03-15       Impact factor: 3.231

10.  Plasma Vanin-1 as a Novel Biomarker of Sepsis for Trauma Patients: A Prospective Multicenter Cohort Study.

Authors:  Hongxiang Lu; Anqiang Zhang; Dalin Wen; Juan Du; Jianhui Sun; Liang Qiao; Dingyuan Du; Wei Gu; Jianxin Jiang
Journal:  Infect Dis Ther       Date:  2021-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.